ArticleJournal of organometallic chemistry2016
Using Hydrazine to Link Ferrocene with Re(CO)
Article in Journal of organometallic chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 12 citations in OpenAlex.
- Computational Design of Rhenium(I) Carbonyl Complexes for Anticancer Photodynamic Therapy.Inorganic chemistry · 2022Article
- Binding a Meridional Ligand in a Facial Geometry: A Square Peg in a Round Hole.Journal of organometallic chemistry · 2021Article
- Lipophilic Re(CO)Dalton transactions (Cambridge, England : 2003) · 2021Article
- Systematically altering the lipophilicity of rhenium(I) tricarbonyl anticancer agents to tune the rate at which they induce cell death.Dalton transactions (Cambridge, England : 2003) · 2020Article
- The synthesis and structures of 1,1'-bis(sulfonyl)ferrocene derivatives.Dalton transactions (Cambridge, England : 2003) · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
Abstract
Acetyl ferrocene and diacetyl ferrocene both readily react with an excess of hydrazine to afford the corresponding hydrazone compounds. These compounds can then be linked to Re(CO)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.